Complete report $3,850.  DataPack (test volumes, sales forecasts, supplier shares) $2,500.The report provides an overview of the cell surface marker testing in Europe (France, Germany, Italy, Spain, UK), including 5-year forecasts for CD4, CD8, CD34 and other markers by country.RationaleThe use of surface marker identification and classification of cells is spreading beyond lymphocytes to the identification of monocytes, macrophages, myeloid stem cells, and tumor cells. A synergistic combination of the hybridoma technology with flow cytometry is further expanding the applications of both technologies. During the next five years, the main trend in cell surface marker analysis will be further simplification of the sample preparation and the analysis itself.This report presents a detailed overview of the CD4, CD8 and CD34 Cell Surface Marker testing in five European countries, including clinical significance and current laboratory practice, as well as five-year test volume forecasts by country and market segment.The report examines market applications of monoclonal antibodies, IT, DNA probes, biochips/microarrays, and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading... Research Beam Model: Research Beam Product ID: 302908 0 USD New
2015-2019 Europe Cell Surface Markers: Hospitals, Commercial Labs, Ambulatory Care Centers-Emerging Opportunities for Instrument and Reagent Suppliers-Competitive Strategies, Country Volume and Sales Segment Forecasts
 
 

2015-2019 Europe Cell Surface Markers: Hospitals, Commercial Labs, Ambulatory Care Centers-Emerging Opportunities for Instrument and Reagent Suppliers-Competitive Strategies, Country Volume and Sales Segment Forecasts

  • Category : Healthcare
  • Published On : July   2015
  • Pages : 125
  • Publisher : VPGMarketResearch.com
 
 
 

Complete report $3,850.  DataPack (test volumes, sales forecasts, supplier shares) $2,500.

The report provides an overview of the cell surface marker testing in Europe (France, Germany, Italy, Spain, UK), including 5-year forecasts for CD4, CD8, CD34 and other markers by country.

Rationale

The use of surface marker identification and classification of cells is spreading beyond lymphocytes to the identification of monocytes, macrophages, myeloid stem cells, and tumor cells. A synergistic combination of the hybridoma technology with flow cytometry is further expanding the applications of both technologies. During the next five years, the main trend in cell surface marker analysis will be further simplification of the sample preparation and the analysis itself.

This report presents a detailed overview of the CD4, CD8 and CD34 Cell Surface Marker testing in five European countries, including clinical significance and current laboratory practice, as well as five-year test volume forecasts by country and market segment.

The report examines market applications of monoclonal antibodies, IT, DNA probes, biochips/microarrays, and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies alternative market penetration strategies and entry barriers/risks.

Contains 125 pages and 24 tables

../toc/TOCTOT%20AnalysisoftheCellSurfaceMarkersinEurope%20HospitalsCLACC.pdf
PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter

 
 

Related Reports

REQUEST SAMPLE    ASK FOR DISCOUNT